Vimarsana
Biggest News Aggregation in the World

Thousand Oaks Based News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thousand Oaks Based. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thousand Oaks Based Today - Breaking & Trending Today

Embattled California Lutheran University president stepping down | Pacific Coast Business Times - Vimarsana News

Embattled California Lutheran University president stepping down | Pacific Coast Business Times

California Lutheran University President Lori Varlotta giving a State of the University address at the Thousand Oaks-based school Feb. 6. (courtesy photo) Four months after the faculty at Thousand Oaks-based California Lutheran University passed a no-confidence resolution, President Lori Varlotta announced that she will be stepping down from her role effective May 31. Announced May 21 right

Affordable housing complex in Oxnard takes applications - Vimarsana News

Affordable housing complex in Oxnard takes applications

Nonprofit developer Many Mansions is taking applications for a new affordable housing complex in south Oxnard.

Source: yahoo.com
Updated: Thousand Oaks biotech firm emerges from stealth with $135M in funding - Vimarsana News

Updated: Thousand Oaks biotech firm emerges from stealth with $135M in funding

Editor's note: This story was updated on Feb. 23 to include more info about the company's lead treatment. Latigo Biotherapeutics, a Thousand Oaks-based biotech firm that was originally founded by Westlake Village BioPartners, emerged from stealth mode on Feb. 14, announcing $135 million in Series A financing. Latigo is a clinical-stage biotechnology company looking to

Thousand Oaks biotech firm emerges from stealth with $135M in funding - Vimarsana News

Thousand Oaks biotech firm emerges from stealth with $135M in funding

Latigo Biotherapeutics, a Thousand Oaks-based biotech firm that was originally founded by Westlake Village BioPartners, emerged from stealth mode on Feb. 14, announcing $135 million in Series A financing. Latigo is a clinical-stage biotechnology company looking to develop non-opioid pain medicines that target pain at its source, according to a press release. Proceeds from the

Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines - Vimarsana News

Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines

/PRNewswire/ -- Latigo Biotherapeutics Inc. ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target...